United BioSource Corporation (UBC), a wholly owned subsidiary of Medco Health Solutions, Inc., today announced the acquisition of Total Healthcare Group (THG), a London-based international consultancy serving clients in the biopharmaceutical industry. THG provides global payer research, strategic planning, and global value dossiers for biopharmaceutical products.
“By combining THG's global payer expertise and research with UBC's scale and its unique portfolio of scientific and late stage research capabilities, we have strengthened our ability to deliver significant value and provide exciting new opportunities for clients throughout our industry”
THG, together with UBC's existing value strategy and research services, will be led by THG's Dr. Robert Hollamby, who has been appointed Senior Vice President at UBC.
"Demonstrating value and providing evidence-based research that allows stakeholders in the health care market to make important economic decisions surrounding biopharmaceuticals and devices is crucial in the market place," said UBC President Mark Clein. "UBC helps clients respond effectively to the evolving health care environment by researching, communicating, and demonstrating value in medicines. The addition of THG significantly expands our capabilities and geographic reach and allows us to launch a comprehensive practice that we expect to be a leader in the global biopharmaceutical industry."
"By combining THG's global payer expertise and research with UBC's scale and its unique portfolio of scientific and late stage research capabilities, we have strengthened our ability to deliver significant value and provide exciting new opportunities for clients throughout our industry," said Dr. Hollamby. "We believe our ability to deliver comprehensive and relevant scientific evidence to payers on a global basis will firmly establish UBC as an industry leader in a discipline that has become crucial to the delivery of high quality health care to patients."
Results International served as THG's financial advisor in this transaction.
Radnet’s DeepHealth and HOPPR forge partnership to advance AI in healthcare